Contemporary Characteristics and Outcomes of Pediatric Oncology Patients Participating in Early Phase Clinical Trials
Overall survival is poor for patients in pediatric oncology early phase trials, despite approximately a quarter having an initial response. These data are informative for discussions between providers and families regarding outcomes after phase 1 trial participation.
Authors
- Steven G. DuBois (ORCID: https://orcid.org/0000-0003-0882-738X)
- Avina Rami (ORCID: https://orcid.org/0000-0002-5509-6033)
- Kevin Campbell (ORCID: https://orcid.org/0000-0003-1826-4277)
- Andrew E. Place (ORCID: https://orcid.org/0000-0002-9604-4213)
- Ketki Bhushan
- Puja J. Umaretiya (ORCID: https://orcid.org/0000-0002-7587-4875)
- Suzanne Shusterman (ORCID: https://orcid.org/0000-0002-5988-1792)
- Kira O'Neil Bona (ORCID: https://orcid.org/0000-0001-5602-7059)
- Karen D. Wright (ORCID: https://orcid.org/0000-0002-9578-1545)
Institutions
- Children's Mercy Hospital (US)
- Harvard University (US)
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/cam4.71222
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00